The University of Chicago Header Logo

Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena.

Immunogenic cell death and cross-priming are reaching the clinical immunotherapy arena. Clin Cancer Res. 2006 Apr 15; 12(8):2385-9.

View in: PubMed